Center for Scientific Review; Notice of Closed Meetings, 31956-31957 [2014-12745]
Download as PDF
<![CDATA[
31956
Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices
sroberts on DSK4SPTVN1PROD with NOTICES
other Agency Bureaus and Offices; (4)
establishes HIV/AIDS program
objectives, alternatives, and policy
positions consistent with broad
Administration guidelines; (5) provides
leadership for and oversight of the
Bureau’s budgetary development and
implementation processes; (6) provides
clinical leadership to Ryan Whitefunded programs and global HIV/AIDS
programs; (7) oversees the
implementation of the training and
systems strengthening for the Global
HIV/AIDS Program as part of the
President’s Emergency Plan for AIDS
Relief; (8) serves as a principal contact
and advisor to the Department and other
parties on matters pertaining to the
planning and development of HIV/
AIDS-related health delivery systems;
(9) reviews HIV/AIDS related program
activities to determine their consistency
with established policies; (10) develops
and oversees operating policies and
procedures for the Bureau; (11) oversees
and directs the planning,
implementation, and evaluation of
special studies related to HIV/AIDS and
public health within the Bureau; (12)
prioritizes technical assistance needs in
consultation with each division/office;
(13) plans, develops, implements and
evaluates the Bureau’s organizational
and staff development, and staff training
activities inclusive of guiding action
steps addressing annual Employee
Viewpoint Survey results; (14) plans,
implements, and evaluates the Bureau’s
national Technical Assistance
conference calls, TARGET Web site,
Webex trainings and other distance
learning modalities; (15) represents the
Agency in HIV/AIDS related
conferences, consultations, and
meetings with other Operating
Divisions, Office of the Assistance
Secretary for Health, the Department of
State, and the White House; (16)
coordinates the development and
distribution of all Bureau
communication activities, materials and
products internally and externally; (17)
provides leadership for and oversees
Bureau’s grants processes, and; (18)
oversees Bureau Executive Secretariat
functions and coordinates HRSA
responses and comments on HIV/AIDSrelated reports, position papers,
guidance documents, correspondence,
and related issues, including Freedom
of Information Act requests.
Division of HIV/AIDS Training and
Capacity Development (RV7)
The Division of HIV/AIDS Training
and Capacity Development provides
national leadership and manages the
implementation of Part F under Title
XXVI of the PHS Act as amended by the
VerDate Mar<15>2010
17:35 Jun 02, 2014
Jkt 232001
Ryan White HIV/AIDS Treatment
Extension Act of 2009, Pub. L. 111–87
(the Ryan White HIV/AIDS Program),
including the Special Projects of
National Significance and the AIDS
Education and Training Centers
Programs. The Special Projects of
National Significance Program develops
innovative models of HIV care and the
AIDS Education and Training Centers
Program increases the number of health
care providers who are educated and
motivated to counsel, diagnose, treat,
and medically manage people with HIV
disease and to help prevent high-risk
behaviors that lead to HIV transmission.
The division also implements the
training and systems strengthening
functions of the Global HIV/AIDS
Program as part of the President’s
Emergency Plan for AIDS Relief
(PEPFAR). This includes strengthening
health systems for delivery of
prevention, care and treatment services
for people living with HIV/AIDS in
PEPFAR funded countries. The division
will translate lessons learned from both
the Global HIV/AIDS Programs and
Special Projects of National Significance
projects to the Part A, B, C, D, and F
grantee community. In collaboration
with the Division of Policy and Data, the
division assesses effectiveness of
technical assistance efforts/initiatives,
identifies new technical assistance
needs and priority areas, and
participates in the bureau-wide
technical assistance workgroup.
Section RV–30, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
Dated: May 27, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014–12726 Filed 6–2–14; 8:45 am]
BILLING CODE 4165–15–P
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Neuroscience.
Date: June 9–10, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pregnancy and Neonatology Study Section.
Date: June 24, 2014.
Time: 7:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: May 28, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–12743 Filed 6–2–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
Center for Scientific Review; Notice of
Closed Meetings
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\03JNN1.SGM
03JNN1
Federal Register / Vol. 79, No. 106 / Tuesday, June 3, 2014 / Notices
sroberts on DSK4SPTVN1PROD with NOTICES
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community-Level Health Promotion Study
Section.
Date: June 23–24, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Chicago Hotel, 505
North Michigan Avenue, Chicago, IL 60611.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Biology.
Date: June 26, 2014.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Svetlana Kotliarova,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
Bethesda, MD 20892, 301–451–3493,
kotliars@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
NIDDK Translational Research.
Date: June 26, 2014.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bleasdale, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170,
MSC 7892, Bethesda, MD 20892, 301–435–
4514, bleasdaleje@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
VerDate Mar<15>2010
17:35 Jun 02, 2014
Jkt 232001
31957
Dated: May 28, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–12745 Filed 6–2–14; 8:45 am]
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; Fellowship, Career
Development, AREA and Conference GrantProgram Announcements.
Date: June 27, 2014.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Dem II,
Suite 401, 6707 Democracy Blvd., Bethesda,
MD 20817, (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D.,
Scientific Review Officer, National Center for
Complementary & Alternative Medicine,
NIH, 6707 Democracy Blvd., Suite 401,
Bethesda, MD 20892, 301–594–3456,
schmidtma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS).
Dated: May 28, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–12748 Filed 6–2–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Hearing
and Balance Clinical Trial.
Date: June 23, 2014.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6001 Executive Blvd.—Room
8343, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; VSL
Clinical Trial.
Date: June 26, 2014.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Christine A. Livingston,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6001 Executive Blvd.—Room
8343, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; Clinical
Trial Review.
Date: June 26, 2014.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Pages 31956-31957]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12745]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 31957]]
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Community-Level Health Promotion Study
Section.
Date: June 23-24, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: InterContinental Chicago Hotel, 505 North Michigan
Avenue, Chicago, IL 60611.
Contact Person: Ping Wu, Ph.D., Scientific Review Officer, HDM
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428,
wup4@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Biology.
Date: June 26, 2014.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Svetlana Kotliarova, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6214, Bethesda, MD 20892, 301-451-3493,
kotliars@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: NIDDK Translational Research.
Date: June 26, 2014.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John Bleasdale, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6170, MSC 7892, Bethesda, MD
20892, 301-435-4514, bleasdaleje@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: May 28, 2014.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-12745 Filed 6-2-14; 8:45 am]
BILLING CODE 4140-01-P
